Antirejection treatment in kidney transplant patients with BK viruria

Transplantation

Volumn 86, Issue 6, 2008, Pages 797-803

  Kayler, Liise K ^a,b   Batal, Ibrahim ^a   Mohanka, Ravi ^a   Morgan, Claire ^a   Basu, Amit ^a   Shapiro, Ron ^a   Randhawa, Parmjeet S ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Kidney transplantation; Polyoma virus; Steroids

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; CREATININE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BK VIRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY GRAFT; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; VIREMIA; AGED; BIOPSY; BLOOD; CHRONIC KIDNEY FAILURE; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS REPLICATION;

AGED; BIOPSY; BK VIRUS; CREATININE; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VIREMIA; VIRUS REPLICATION;

EID: 56049127155     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181837802     Document Type: Article

References (27)

1. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611.
2. Mannon RB. Polyomavirus nephropathy: What have we learned? Transplantation 2004; 9: 1313.
3. Hirsch HH. Polyomavirus BK nephropathy: A (re-)emerging complication in renal transplantation. Am J Transplant 2002; 2: 25.
4. Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918.
5. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med 2000; 342: 1361.
6. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal transplant recipients. N Engl J Med 2002; 347: 488.
7. Koss LG. Inflammatory processes within the lower urinary tract. Diagnostic cytology and its histopathologic bases. Philadelphia, J. B. Lippincott Company 1992, pp 909-913.
8. Kahan AV, Coleman DV, Koss LG. Activation of human polyomavirus infection-detection by cytologic technics. Am J Clin Pathol 1980; 74: 326.
9. Kim SH, Ahn HJ, Kim YS, et al. Urinary HLA-DR and CD54 expression-Indicators for inflammatory activity in decoy cell shedding patients. Nephrol Dial Transplant 2006; 21: 2601.
10. Mayr M, Nickeleit V, Hirsch HH, et al. Polyomavirus BK nephropathy in a kidney transplant recipient: Critical issues of diagnosis and management. Am J Kidney Dis 2001; 38: 13E.
11. RahimimovR,Lustig S, TovarA,et al.BK poloma virus nephropathy in kidney transplant recipient: The role of new immunosuppressive agents. Transpl Proc 2003; 35: 604.
12. Limaye AP, Keith RJ, Kuhr CS, et al. Quantitiation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. qJ Infect Dis 2001; 183: 1669.
13. Funk GA, Steiger J, Hirsch HH. Rapid dynamics of polyomavirus type BK in renal transplant recipients. J Infect Dis 2006; 193: 80.
14. Chen Y, Trofe J, Gordon J, et al. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 2006; 80: 3495.
15. Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006; 81: 704.
16. Vasudev B, Hariharan S, Hussain SA, et al. BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients. qKidney Int 2005; 68: 1834.
17. Solez K, Colvin RB, Racusen LC, et al. Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN). Am J Trans 2007; 7: 518.
18. Randhawa PS, Vats A, Zygmunt D, et al. Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation 2002; 74: 485.
19. Nickeleit V, Zeiler M, Gudat F, et al. Histological characteristics of interstitial renal allograft rejection. Kidney Blood Press Res 1998; 21: 230.
20. Celik B, Shapiro R, Vats A, et al. Polyomavirus allograft nephropathy: Sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am J Transpl 2003; 3: 1378.
21. Randhawa P, Brennan DC. BK virus infection in transplant recipients: An overview and update. Am J Transpl 2006; 6: 2000.
22. Nickeleit V, Singh HK, Mihatsch MJ. Polyomavirus nephropathy: Morphology, pathophysiology, and clinical management. Curr Opin Nephrol Hypertens 2003; 12: 599.
23. Wadei HM, Rule AD, Lewin M. Kidney transplant function and histolog-ical clearance of virus following diagnosis of polyomavirus-associated ne-phropathy (PVAN). Am J Transplant 2006; 6(5 Pt 1): 1025.
24. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145.
25. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J Am Soc Nephrol 1999; 10: 1080.
26. Randhawa P, Vats A, Shapiro R. Monitoring for polyomavirus BK and JC in urine: Comparison of quantitative polymerase chain reaction with urine cytology. Transplantation 2005; 79: 984.
27. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277.